Moringa concanensis L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1β in BALB/c Mice.

MLA

Kim, Kyeong-Min, et al. “Moringa Concanensis L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1β in BALB/c Mice.” Pharmaceuticals (Basel, Switzerland), vol. 15, no. 10, Sept. 2022. EBSCOhost, https://doi.org/10.3390/ph15101217.

APA

Kim, K.-M., Kim, S.-Y., Mony, T. J., Bae, H. J., Choi, S.-H., Choi, Y.-Y., An, J.-Y., Kim, H.-J., Cho, Y. E., Sowndhararajan, K., & Park, S. J. (2022). Moringa concanensis L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1β in BALB/c Mice. Pharmaceuticals (Basel, Switzerland), 15(10). https://doi.org/10.3390/ph15101217

Chicago

Kim, Kyeong-Min, So-Yeon Kim, Tamanna Jahan Mony, Ho Jung Bae, Seung-Hyuk Choi, Yu-Yeong Choi, Ju-Yeon An, et al. 2022. “Moringa Concanensis L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1β in BALB/c Mice.” Pharmaceuticals (Basel, Switzerland) 15 (10). doi:10.3390/ph15101217.